Deepak Fertilisers & Petrochemicals Corporation Ltd (DFPCL) and Yara International ASA have signed a Heads of Agreement with the intention of establishing a joint venture Company (JV) to produc
Glenmark Pharmaceuticals Ltd has announced that its Swiss unit, Glenmark Pharmaceuticals SA, has received USD 15 Million as milestone fees from Forest Laboratories, its North American partner, for an anti-asthma drug Oglemilast molecule.
Both companies are working together to initiate additional studies for further longer term development of oglemilast, including a Phase II study in Asthma.